NCT05800834 2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
Instituto Nacional de Cancer, Brazil
Zhongda Hospital
The Netherlands Cancer Institute
Tetra Bio-Pharma
Assiut University
Federal University of São Paulo
University of Illinois College of Medicine at Peoria
Istanbul University
McGill University Health Centre/Research Institute of the McGill University Health Centre
Akela Pharma, Inc.